Finance

Lists
PBV:FRA
Prestige Consumer Healthcare Inc
40,80 €
+1,49%
(+0,60) 1D
7 հոկ, 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for PBV...
Open
40,80 €
High
40,80 €
Low
40,80 €
Mkt. cap
2,25 մլրդ
Avg. vol.
0,00
Volume
0,00
52-wk high
60,00 €
52-wk low
38,00 €
No. of employees
890
Open
40,80 €
High
40,80 €
Low
40,80 €
Mkt. cap
2,25 մլրդ
Avg. vol.
0,00
Volume
0,00
52-wk high
60,00 €
52-wk low
38,00 €
No. of employees
890
News stories
From web sources and news partners
Profile
Prestige Consumer Healthcare Inc. is an American company that markets and distributes over-the-counter healthcare and household cleaning products. It was formed by the merger of Medtech Products, Inc., Prestige Brands International, and the Spic and Span Company in 1996. The company is headquartered in Tarrytown, New York and operates a manufacturing facility in Lynchburg, Virginia. Among the brands owned by Prestige are Chloraseptic sore throat products, Clear Eyes, Compound W wart treatment, Dramamine motion sickness treatment, Efferdent denture care, Luden's throat drops, BC Powder and Goody's Headache Powder, Pediacare & Little Remedies children's OTC products and Beano. The company's CEO and president is Ron Lombardi, who replaced Matthew Mannelly on June 1, 2015. Wikipedia
About Prestige Consumer Healthcare Inc
CEOMatthew M. Mannelly
Employees890
Founded1996
Headquarters-
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
274,11 մլն
283,44 մլն
281,62 մլն
265,71 մլն
Cost of goods sold
120,04 մլն
123,63 մլն
132,40 մլն
123,63 մլն
Cost of revenue
120,04 մլն
123,63 մլն
132,40 մլն
123,63 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
66,74 մլն
69,73 մլն
65,37 մլն
77,97 մլն
Operating expense
74,40 մլն
77,32 մլն
73,72 մլն
86,72 մլն
Total operating expenses
194,44 մլն
200,95 մլն
206,12 մլն
210,35 մլն
Operating income
79,67 մլն
82,49 մլն
75,49 մլն
55,36 մլն
Other non operating income
-501,00 հզր
-10,00 մլն
708,00 հզր
-34,00 հզր
EBT including unusual items
69,13 մլն
61,81 մլն
64,77 մլն
38,54 մլն
EBT excluding unusual items
69,13 մլն
61,81 մլն
64,77 մլն
41,38 մլն
Income tax expense
26,92 մլն
15,12 մլն
10,84 մլն
9,36 մլն
Effective tax rate
38,94%
24,46%
16,74%
24,30%
Other operating expenses
-
-
-
-
Net income
42,21 մլն
46,70 մլն
53,93 մլն
29,18 մլն
Net profit margin
15,40%
16,47%
19,15%
10,98%
Earnings per share
0,86
1,14
1,23
0,98
Interest and investment income
-
-
-
-
Interest expense
-10,04 մլն
-10,67 մլն
-11,43 մլն
-13,94 մլն
Net interest expenses
-10,04 մլն
-10,67 մլն
-11,43 մլն
-13,94 մլն
Depreciation and amortization charges
7,66 մլն
7,59 մլն
8,35 մլն
8,75 մլն
EBITDA
87,33 մլն
90,08 մլն
83,84 մլն
64,11 մլն
Gain or loss from assets sale
131,00 հզր
9,00 հզր
25,00 հզր
191,00 հզր
AI content may include mistakes. Learn more
Google Apps